Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more
Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Market Cap
158.1M
52 Wk Range
$1.26 - $8.59
Previous Close
$1.58
Open
$1.59
Volume
101,046
Day Range
$1.54 - $1.61
Enterprise Value
172.2M
Cash
25.93M
Avg Qtr Burn
-21.56M
Insider Ownership
33.78%
Institutional Own.
26.81%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|